Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The value of immunization against hepatitis A

S M Lemon1, C N Shapiro

  • 1Department of Medicine, University of North Carolina at Chapel Hill 27599-7030.

Infectious Agents and Disease
|February 1, 1994
PubMed
Summary

New inactivated vaccines for hepatitis A virus (HAV) infection are coming. Targeted immunization alone won't reduce national rates, but regional strategies may be effective.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.

Vaccine·2013
Same author

Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer.

Oncogene·2011
Same author

Role of Hepatitis C virus core protein in viral-induced mitochondrial dysfunction.

Journal of viral hepatitis·2009
Same author

Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens.

Gut·2009
Same author

Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2005
Same author

A rapid immunochromatographic assay for hepatitis B virus screening.

Journal of viral hepatitis·2003

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • Hepatitis A virus (HAV) infection poses a significant public health concern in the United States.
  • Inactivated vaccines for HAV prevention are nearing availability.
  • Disease distribution varies across risk, age, and geographic groups.

Purpose of the Study:

  • To review the epidemiology of HAV cases in the US.
  • To evaluate potential strategies for HAV vaccine implementation.
  • To determine the most effective approach for reducing national HAV rates.

Main Methods:

  • Review of existing data on HAV case distribution.
  • Analysis of different immunization program strategies.
  • Epidemiological assessment of risk and geographic factors.

Main Results:

  • Exclusive targeting of high-risk groups is unlikely to significantly decrease national HAV rates.
  • Universal immunization of young children could reduce rates but may be prohibitively expensive.
  • Heterogeneous distribution of HAV cases necessitates tailored approaches.

Conclusions:

  • Immunization strategies must consider local HAV epidemiology.
  • Regional, risk-group-targeted vaccination programs are a viable alternative.
  • A combination of approaches may be necessary for optimal disease control.

Related Experiment Videos